Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572552
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymarin in Adult Patients With SepsisTanta UniversityNot Yet RecruitingPhase 2
NCT07572552Not Yet Recruiting
Phase 2
Clinical Study Evaluating the Efficacy and Safety of Fenofibrates Versus Silymar...Tanta University
NCT07572045
Promoting Interventions for Climate Change to Upscale Resilience in District BadinDr Jai Kumar DasNot Yet RecruitingNot Applicable
NCT07572045Not Yet Recruiting
Not Applicable
Promoting Interventions for Climate Change to Upscale Resilience in District Bad...Dr Jai Kumar Das
NCT07572747
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf CountriesKhalid F AlhabibNot Yet RecruitingPhase 3
NCT07572747Not Yet Recruiting
Phase 3
Aspirin Versus Clopidogrel in Chronic Coronary Syndrome in Arabian Gulf Countrie...Khalid F Alhabib
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07572006
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Development, LLCNot Yet RecruitingPhase 1
NCT07572006Not Yet Recruiting
Phase 1
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesJanssen Research & Develo...
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07572435
Preliminary Efficacy of a Remote Cardiac Rehabilitation Program in Pediatric Patients With Complex Congenital Heart DiseaseSeoul National University HospitalRecruitingNot Applicable
NCT07572435Recruiting
Not Applicable
Preliminary Efficacy of a Remote Cardiac Rehabilitation Program in Pediatric Pat...Seoul National University...
NCT07573124
Efficacy of Combining Mulligan Spinal Mobilization With Leg Movement and Mechanical Lumbar Traction in Lumbar RadiculopathyKhyber Medical University PeshawarRecruitingNot Applicable
NCT07573124Recruiting
Not Applicable
Efficacy of Combining Mulligan Spinal Mobilization With Leg Movement and Mechani...Khyber Medical University...
NCT07572071
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's DiseaseIran University of Medical SciencesRecruitingPhase 1
NCT07572071Recruiting
Phase 1
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Park...Iran University of Medica...
NCT07572292
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine PositionVrije Universiteit BrusselNot Yet RecruitingNot Applicable
NCT07572292Not Yet Recruiting
Not Applicable
Proof of Concept for Simulating Static Weight-bearing Exercises in the Supine Po...Vrije Universiteit Brusse...
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07573800
tDCS and the Cardiovascular System in Community-dwelling Elderly.Riphah International UniversityNot Yet RecruitingNot Applicable
NCT07573800Not Yet Recruiting
Not Applicable
tDCS and the Cardiovascular System in Community-dwelling Elderly.Riphah International Univ...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07574268
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled TrialMenoufia UniversityCompletedPhase 4
NCT07574268Completed
Phase 4
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men Wi...Menoufia University
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07573449
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male ParticipantsOtsuka Pharmaceutical Development & Commercialization, Inc.CompletedPhase 1
NCT07573449Completed
Phase 1
How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Si...Otsuka Pharmaceutical Dev...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting5 (25%)
Completed3 (15%)
not_applicable9 (45%)
Phase 24 (20%)
Phase 14 (20%)
Phase 31 (5%)
Phase 41 (5%)
Not Specified1 (5%)